Siglec-7 antibodies (Palleon Pharma)

N/A

Report date: 2025/01/26 16:58:17

Base Information

Drug NameSiglec-7 antibodies (Palleon Pharma)
Drug Alias Namesiglec-7 checkpoint inhibitor (Palleon Pharma)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionSialic acid-binding Ig-like lectin 7 inhibitors
TargetsSialic acid-binding Ig-like lectin 7
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPalleon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPalleon Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A